4-114827915-A-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022569.3(NDST4):c.2520T>G(p.Asn840Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
NDST4
NM_022569.3 missense
NM_022569.3 missense
Scores
19
Clinical Significance
Conservation
PhyloP100: 0.135
Genes affected
NDST4 (HGNC:20779): (N-deacetylase and N-sulfotransferase 4) Predicted to enable [heparan sulfate]-glucosamine N-sulfotransferase activity and deacetylase activity. Predicted to be involved in heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process. Predicted to be located in Golgi membrane. Predicted to be integral component of membrane. Predicted to be active in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.062228978).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDST4 | NM_022569.3 | c.2520T>G | p.Asn840Lys | missense_variant | 14/14 | ENST00000264363.7 | NP_072091.1 | |
NDST4 | XM_017008545.3 | c.1383T>G | p.Asn461Lys | missense_variant | 13/13 | XP_016864034.1 | ||
NDST4 | XM_017008546.2 | c.1383T>G | p.Asn461Lys | missense_variant | 12/12 | XP_016864035.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NDST4 | ENST00000264363.7 | c.2520T>G | p.Asn840Lys | missense_variant | 14/14 | 1 | NM_022569.3 | ENSP00000264363.2 | ||
NDST4 | ENST00000504854.1 | n.*371T>G | non_coding_transcript_exon_variant | 13/13 | 1 | ENSP00000423218.1 | ||||
NDST4 | ENST00000504854.1 | n.*371T>G | 3_prime_UTR_variant | 13/13 | 1 | ENSP00000423218.1 | ||||
NDST4 | ENST00000613194 | c.*371T>G | 3_prime_UTR_variant | 15/15 | 5 | ENSP00000483949.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | The c.2520T>G (p.N840K) alteration is located in exon 14 (coding exon 13) of the NDST4 gene. This alteration results from a T to G substitution at nucleotide position 2520, causing the asparagine (N) at amino acid position 840 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Gain of methylation at N840 (P = 0.0157);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at